Related Experiment Video
Updated: Aug 15, 2026

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
Role of DNA 5-methylcytosine transferase in cell transformation by fos
1Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Abstract:
The Fos and Jun oncoproteins form dimeric complexes that stimulate transcription of genes containing activator protein-1 regulatory elements. We found, by representational difference analysis, that expression of DNA 5-methylcytosine transferase (dnmt1) in fos-transformed cells is three times the expression in normal fibroblasts and that fos-transformed cells contain about 20 percent more 5-methylcytosine than normal fibroblasts. Transfection of the gene encoding Dnmt1 induced morphological transformation, whereas inhibition of dnmt1 expression or activity resulted in reversion of fos transformation. Inhibition of histone deacetylase, which associates with methylated DNA, also caused reversion. These results suggest that fos may transform cells through alterations in DNA methylation and in histone deacetylation.
Insights
The Fos oncoprotein transforms cells by increasing DNA methylation and histone deacetylation. Inhibiting these processes, specifically DNA methyltransferase 1 (dnmt1), reverses Fos-induced cell transformation.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Fos and Jun oncoproteins form dimers that activate transcription via activator protein-1 (AP-1) sites.
- Cellular transformation by oncogenes can involve epigenetic modifications.
- DNA methylation and histone deacetylation are key epigenetic regulatory mechanisms.
Purpose of the Study:
- To investigate the role of DNA methylation and histone deacetylation in Fos-mediated cellular transformation.
- To determine if alterations in DNA methyltransferase 1 (dnmt1) expression are associated with Fos transformation.
- To explore the therapeutic potential of targeting epigenetic modifications in Fos-transformed cells.
Main Methods:
- Representational difference analysis (RDA) to compare gene expression between normal and Fos-transformed fibroblasts.
- Quantitative analysis of 5-methylcytosine levels in cellular DNA.
- Transfection assays to introduce the Dnmt1 gene.
- Inhibition studies targeting dnmt1 expression/activity and histone deacetylase (HDAC).
Main Results:
- Fos-transformed cells exhibited a threefold increase in DNA 5-methylcytosine transferase (dnmt1) expression compared to normal fibroblasts.
- Fos-transformed cells showed approximately 20% higher 5-methylcytosine content in their DNA.
- Overexpression of Dnmt1 induced morphological transformation, mimicking Fos transformation.
- Inhibition of dnmt1 or histone deacetylase activity led to the reversion of Fos-induced cell transformation.
Conclusions:
- Fos-mediated cellular transformation appears to be driven by epigenetic alterations, specifically increased DNA methylation and histone deacetylation.
- DNA methyltransferase 1 (dnmt1) plays a critical role in the transformation process induced by Fos.
- Targeting epigenetic regulators like dnmt1 and HDACs offers a potential therapeutic strategy against Fos-driven cancers.
Related Concept Videos
Bacterial Transformation
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
DNA Damage Can Stall the Cell Cycle
Somatic to iPS Cell Reprogramming
Transformation

